Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study

Int J Clin Oncol. 2021 May;26(5):951-953. doi: 10.1007/s10147-021-01880-5.
No abstract available

Publication types

  • Published Erratum